On January 10, 2020, the first whole-genome sequences of SARS-CoV-2 were made available on GISAID. This enabled global responses to the pandemic. There was the first vaccines, and diagnostic tests, to detect SARS-CoV-2. GISAID helps watch for the emergence of new COVID-19 viral strains across the planet.